Pharmacy Europe - Anti-drooling drug wins approval

Links shared publicly online about this topic.

  • 985
    total visits

Pharmacy Europe - Anti-drooling drug wins approval

pharmacyeurope.net

Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.

View full resource at pharmacyeurope.net

Tags: Drug, Pharma, FDA, Pharmacy Professions, Pharmacist, News

  • Share

Most Recently Shared on July 30, 2010 at 11:40 am By:

Drugs_Devices Drugs and Devices OW

Anti-drooling drug wins approval: FDA approves medication developed by Japanese company to fight heavy drooling in... http://bit.ly/9DR7Yk

2 years ago...

Abbott wins EU approval for new use of Humira drug | Reuters

reuters.com — “(Reuters) - Humira, the best-selling arthritis drug that forms the cornerstone of Abbott Laboratories' pharmaceutical business, has been approved in Europe for ulcerative colitis, the U.S. drugmaker saidView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 11, 2012 at 6:12 am By:

Drugs_Devices Drugs and Devices OW OW Health

Abbott wins EU approval for new use of Humira drug - Reuters: Abbott wins EU approval for new use of Humir... http://t.co/LSZvbDEi #drug

2 months ago...

Boehringer-Lilly's Trajenta wins European approval | InPharm

inpharm.com — “Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been approved EuropeView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on August 26, 2011 at 10:05 am By:

Pharmafocus Pharmafocus Health News and Pharma

Boehringer-Lilly's Trajenta wins European approval http://ow.ly/6dnH8 #diabetes #pharma

9 months ago...

UPDATE 1-Biogen wins conditional approval for MS drug in EU | Reuters

reuters.com — “* Europe gives conditional approval to Fampyra * Regulators recommend Biogen conduct additional study * Study to evaluate safety, efficacy over the long term BOSTON, July 25 (Reuters) - Biogen IdecView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on July 25, 2011 at 2:17 pm By:

FierceBiotech FierceBiotech Health News

Biogen grabs MS drug OK in EU, http://reut.rs/paQF7I (a feather in $BIIB's cap ahead of earnings this week?)

10 months ago...

Novartis eye drug wins wider European licence | InPharm

inpharm.com — “Novartis' Lucentis approved in Europe to treat people suffering from vision loss due to macular oedema secondary to RVOView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 12:12 pm By:

Pharmafocus Pharmafocus Health News and Pharma

Novartis eye drug wins wider European licence http://goo.gl/fb/KC43I

12 months ago...

GSK and HGS lupus drug wins green light in Europe | Reuters

reuters.com — “LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar sales expectationsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on May 20, 2011 at 5:00 pm By:

hrana Hisham Rana, MD Doctor and Physician

News: GSK and HGS lupus drug wins green light in Europe http://reut.rs/jPusCG - #health #pharma

1 year ago...

GSK, HGS lupus drug wins green light in Europe | Reuters

reuters.com — “LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar sales expectationsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on May 20, 2011 at 2:52 pm By:

GSK and HGS lupus drug wins green light in Europe | Reuters

reuters.com — “LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar sales expectationsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on May 20, 2011 at 2:49 pm By:

HealthNews2 Health News Health News

GSK and HGS lupus drug wins green light in Europe: LONDON (Reuters) - The first new treatment for ... http://bit.ly/mdWZpo #health #news

1 year ago...

GSK and HGS lupus drug wins green light in Europe | Reuters

reuters.com — “LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar sales expectationsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on May 20, 2011 at 2:49 pm By:

HITpol HealthIT Policy Health News and Health IT

GSK and HGS lupus drug wins green light in Europe: LONDON (Reuters) - The first new treatment for lupus in a hal... http://bit.ly/m3qqJJ

1 year ago...

Pharmacy Europe - FDA approves anti-clotting drug

pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.View full resource at pharmacyeurope.net

  • View Related
  • Share

Most Recently Shared on October 26, 2010 at 10:17 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA approves anti-clotting drug: The US Food and Drug Administration has approved a new drug that can reduce the r... http://bit.ly/aL6fsF

2 years ago...

Pharmacy Europe - Merck KGaA hopes for drug approval

pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.View full resource at pharmacyeurope.net

  • View Related
  • Share

Most Recently Shared on August 17, 2010 at 10:56 am By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Merck KGaA hopes for drug approval: Merck KGaA has submitted its multiple sclerosis tablet Cladribine for US gover... http://bit.ly/bavXH7

2 years ago...

Pharmacy Europe - FDA "backs transplant patient drug"

pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.View full resource at pharmacyeurope.net

  • View Related
  • Share

Most Recently Shared on August 13, 2010 at 10:52 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA "backs transplant patient drug": America's FDA has approved a longer length of therapy for a medication treati... http://bit.ly/cdDnBg

2 years ago...

Pharmacy Europe - Merck seeking approval for MS pill

pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.View full resource at pharmacyeurope.net

  • View Related
  • Share

Most Recently Shared on June 8, 2010 at 5:49 pm By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Merck seeking approval for MS pill: The battle to win US approval for the first multiple sclerosis (MS) pill has b... http://bit.ly/c4CYEc

2 years ago...

Bone drug from Amgen and Glaxo wins EU approval - Yahoo! News UK

uk.news.yahoo.com — “Amgen's keenly awaited new drug Prolia, or denosumab, has been approved in Europe as a treatment for the brittle bone disease osteoporosis, the U.S. biotech giant said onView full resource at uk.news.yahoo.com

  • View Related
  • Share

Most Recently Shared on May 28, 2010 at 10:12 am By:

Dermatology_OW Dermatology Wisdom OW Health

Bone drug from Amgen and Glaxo wins EU approval: Amgen's keenly awaited new drug Prolia, or denosumab, has been ap... http://bit.ly/aZV3uf

2 years ago...

Pharmacy Europe - New birth control poll approved

pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.View full resource at pharmacyeurope.net

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 4:36 pm By:

Drugs_Devices Drugs and Devices OW OW Health

New birth control poll approved: The Food and Drug Administration (FDA) has approved the first four-phase oral con... http://bit.ly/ao3wgn

2 years ago...

Bayer wins U.S. approval for new birth control pill | Reuters

reuters.com — “WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Thursday it approved Bayer AG's new birth control pill Natazia. The pill, already licensed in Europe under the brand name Qlaira,View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on May 7, 2010 at 5:00 am By:

hrana Hisham Rana, MD Doctor and Physician

News: Bayer wins U.S. approval for new birth control pill Natazia http://bit.ly/apShgw - It's known as Qlaira in Europe. #health

2 years ago...

Advertisement